May
25
Friday

MNK 16.50 +0.06 (0.36%)

Sections on this page: Stock Price | Stock Charts | Company Profile | Earnings


Would you like to receive important updates about Mallinckrodt PLC like earnings dates and more?

Add (MNK) to Portfolio

MNK Stock Price Today $16.50

 The recent MNK stock price today is $16.50 +0.06 (0.36%) for Fri, May 25, 2018.

Year To Date

The Year To Date (YTD) return is -29.85%.

52 Week Low

May
04
Friday

The 52 Week Low stock price is 11.65 set on Fri, May 4, 2018 which is 22 days ago.

The current price per share is 41.63% above the 52 week low.

52 Week High

Jul 2017
25
Tuesday

The 52 Week High stock price is $49.12 set on Tue, Jul 25, 2017 which is 305 days ago.

The current price per share is -66.41% below the 52 week high.

All Time High

Mar 2015
23
Monday

The All Time High stock price is $134.26 set on Mon, Mar 23, 2015 which is 1,160 days ago.

The current price per share is -87.71% below the all time high.

Mallinckrodt Stock Charts

The 5 year and 1 year stock charts are below.

5 Year Stock Chart

The Mallinckrodt 5 year stock chart shows the historical prices over the previous 60 months.

Mallinckrodt 5 year stock chart

1 Year Stock Chart

The Mallinckrodt 1 year stock chart shows the historical prices over the previous 12 months.

Mallinckrodt 1 year stock chart

50 Day Moving Average

The 50 Day Moving Average is at $14.35 which is 14.98% below the stock price of $16.50.

200 Day Moving Average

The 200 Day Moving Average is at 23.37 which is -29.40% below the stock price of $16.50.

MNK Company Profile

Mallinckrodt PLC LogoMallinckrodt PLC is a Health Care stock that trades on the NYSE and has a market capitalization of $1.37 Billion.

http://www.mallinckrodt.comMallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.

For more information and analysis about Mallinckrodt PLC, visit their web site at http://www.mallinckrodt.com. For a real time price lookup on this ticker, MNK, visit Google Finance and Bloomberg.

Below are several other Biotech & Pharma stocks include AbbVie Inc (ABBV), Allergan PLC (AGN), Alexion Pharmaceuticals Inc (ALXN), Amgen Inc (AMGN), Biogen Inc (BIIB), BioMarin Pharmaceutical Inc (BMRN), Bristol-Myers Squibb Co (BMY), Celgene Corp (CELG), Endo International PLC (ENDP), Gilead Sciences Inc (GILD), .

MNK Earnings

 Below is the EPS, P/E Ratio and Earnings Date.

Earnings Per Share

The EPS is $21.80.

Price To Earnings Ratio

The P/E Ratio is 0.76

Earnings Dates

Stocks can make big percentage moves on the earnings announcement.

Companies announce earnings either before the market open or after the close.

Feb
27
Tuesday

The Earnings Release Date for Mallinckrodt PLC was Tue, Feb 27, 2018.

Since this earnings release 88 days ago, the stock price is up by +1.91%.

May
08
Tuesday

The most recent Earnings Release Date was on Tue, May 8, 2018, which was 18 days ago.

Since this earnings date, the stock price is up by +29.11%.

Mallinckrodt Dividend

MNK currently does not pay a dividend.

You may like this list of best dividend stocks of 2018.